呼吸ガスモニター：市場洞察・競合環境・市場予測 (～2030年)

喘息、COPD、肺炎などの呼吸器疾患の有病率の上昇が、病院や在宅ケア環境における連続呼吸モニタリングの需要を促進しています。さらに、世界の外科手術の増加により、正確な麻酔モニタリングの必要性が高まっており、呼吸ガスモニターは患者の安全を確保するために酸素とCO2レベルの追跡において重要な役割を果たしています。効果的な麻酔ケアに対する需要の高まりと技術の進歩により、市場の主要企業はより多くの製品を発売し、規制当局の承認を得ています。ワイヤレス接続やリアルタイムのデータ分析などの強化された機能を備えたこれらの新しいデバイスは、ヘルスケアプロバイダーや患者の進化するニーズを満たすことで、市場の成長をさらに後押ししています。これらの要因が相まって、2024年から2030年までの予測期間中、呼吸ガスモニターの市場は活性化すると予測されています。

呼吸ガスモニター：市場力学

Australian Institute of Health and Welfareの最新データによると、2022年にはオーストラリアで約850万人 (34%) が慢性呼吸器疾患を患っていると推定されています。

また、Global Burden of Disease (2023年) の最新データによると、世界では約20人に1人が慢性呼吸器疾患に罹患しています。

さらに、WHOが提供した最近のデータと統計 (2024年) によると、喘息は世界で推定2億6,200万人が罹患しています。喘息、慢性閉塞性肺疾患 (COPD)、肺感染症などの呼吸器疾患の増加は、呼吸ガスモニター市場を大きく牽引しています。酸素、二酸化炭素、その他の呼吸ガスの継続的なモニタリングを必要とする患者の増加に伴い、病院や診療所はより良いケアを提供するために高度なモニタリングシステムを採用しています。これらの機器は、呼吸困難の早期徴候を検出し、治療計画を最適化し、患者の転帰を改善するのに役立ちます。慢性呼吸器疾患の増加により、医療施設や家庭での長期モニタリングの必要性も高まっており、ポータブルで非侵襲的な呼吸ガスモニターの需要がさらに高まっています。

デバイス別では、パルスオキシメーターが2023年にかなりの市場シェアを占めると予測されています。パルスオキシメーターは、患者の酸素飽和度 (SpO2) と心拍数をモニタリングするための費用対効果の高い非侵襲的ソリューションを提供することで、呼吸ガスモニター市場全体に大きな影響を与えています。病院、外来診療所、在宅ケアなど、さまざまな医療環境で広く採用されていることが、呼吸モニタリングソリューションの需要を押し上げています。特に慢性閉塞性肺疾患 (COPD) や喘息などの呼吸器疾患を持つ患者の管理や外科手術の際には、パルスオキシメーターが提供する使いやすさと迅速な結果は、医療提供者にとって不可欠なツールとなっています。

当レポートでは、世界の呼吸ガスモニターの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 呼吸ガスモニター市場レポート：イントロダクション

• 調査範囲
• 市場の分類
• 市場の想定

第2章 呼吸ガスモニター市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 呼吸ガスモニター市場：主要要因分析

• 市場促進要因
  • 呼吸器疾患の罹患率の上昇
  • 世界で外科手術件数が増加
  • 麻酔モニタリングの需要の増加
• 市場抑制要因と課題
  • 製品リコールの増加
  • 製品承認に関する厳格な規制上の懸念
• 市場機会
  • 呼吸ガスモニターにおけるAIと遠隔医療サービスの統合

第6章 呼吸ガスモニター市場：ポーターのファイブフォース分析

第7章 呼吸ガスモニター市場の評価

• デバイス別
  • カプノグラフ
  • パルスオキシメーター
  • スパイロメーター
  • その他
• エンドユーザー別
  • 病院
  • クリニック
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 呼吸ガスモニター市場：企業・製品プロファイル

• Medtronic plc.
• Koninklijke Philips N.V.
• Nihon Kohden Corporation
• Dragerwerk AG & Co. KGaA
• Stryker
• GE Healthcare
• ndd Medical Technologies
• VYAIRE
• Baxter
• Contec
• Zoll Medical Corporation
• ICU Medical
• Hamilton Medical
• Avante Health Solutions
• Nonin
• BD
• EDAN Instruments, Inc.
• Criticare Technologies, Inc.
• HILLROM
• Masimo

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Respiratory Gas Monitors Market in Global (2021-2030)
• Table 3: Respiratory Gas Monitors Market in Global by Device (2021-2030)
• Table 4: Respiratory Gas Monitors Market in Global by End-User (2021-2030)
• Table 5: Respiratory Gas Monitors Market in Global by Geography (2021-2030)
• Table 6: Respiratory Gas Monitors Market in North America (2021-2030)
• Table 7: Respiratory Gas Monitors Market in the United States (2021-2030)
• Table 8: Respiratory Gas Monitors Market in Canada (2021-2030)
• Table 9: Respiratory Gas Monitors Market in Mexico (2021-2030)
• Table 10: Respiratory Gas Monitors Market in Europe (2021-2030)
• Table 11: Respiratory Gas Monitors Market in France (2021-2030)
• Table 12: Respiratory Gas Monitors Market in Germany (2021-2030)
• Table 13: Respiratory Gas Monitors Market in United Kingdom (2021-2030)
• Table 14: Respiratory Gas Monitors Market in Italy (2021-2030)
• Table 15: Respiratory Gas Monitors Market in Spain (2021-2030)
• Table 16: Respiratory Gas Monitors Market in the Rest of Europe (2021-2030)
• Table 17: Respiratory Gas Monitors Market in Asia-Pacific (2021-2030)
• Table 18: Respiratory Gas Monitors Market in China (2021-2030)
• Table 19: Respiratory Gas Monitors Market in Japan (2021-2030)
• Table 20: Respiratory Gas Monitors Market in India (2021-2030)
• Table 21: Respiratory Gas Monitors Market in Australia (2021-2030)
• Table 22: Respiratory Gas Monitors Market in South Korea (2021-2030)
• Table 23: Respiratory Gas Monitors Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Respiratory Gas Monitors Market in the Rest of the World (2021-2030)
• Table 25: Respiratory Gas Monitors Market in the Middle East (2021-2030)
• Table 26: Respiratory Gas Monitors Market in Africa (2021-2030)
• Table 27: Respiratory Gas Monitors Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Respiratory Gas Monitors Market in Global (2021-2030)
• Figure 3: Respiratory Gas Monitors Market in Global by Device (2021-2030)
• Figure 4: Respiratory Gas Monitors Market in Global by End-User (2021-2030)
• Figure 5: Respiratory Gas Monitors Market in Global by Geography (2021-2030)
• Figure 6: Respiratory Gas Monitors Market in North America (2021-2030)
• Figure 7: Respiratory Gas Monitors Market in the United States (2021-2030)
• Figure 8: Respiratory Gas Monitors Market in Canada (2021-2030)
• Figure 9: Respiratory Gas Monitors Market in Mexico (2021-2030)
• Figure 10: Respiratory Gas Monitors Market in Europe (2021-2030)
• Figure 11: Respiratory Gas Monitors Market in France (2021-2030)
• Figure 12: Respiratory Gas Monitors Market in Germany (2021-2030)
• Figure 13: Respiratory Gas Monitors Market in United Kingdom (2021-2030)
• Figure 14: Respiratory Gas Monitors Market in Italy (2021-2030)
• Figure 15: Respiratory Gas Monitors Market in Spain (2021-2030)
• Figure 16: Respiratory Gas Monitors Market in the Rest of Europe (2021-2030)
• Figure 17: Respiratory Gas Monitors Market in Asia-Pacific (2021-2030)
• Figure 18: Respiratory Gas Monitors Market in China (2021-2030)
• Figure 19: Respiratory Gas Monitors Market in Japan (2021-2030)
• Figure 20: Respiratory Gas Monitors Market in India (2021-2030)
• Figure 21: Respiratory Gas Monitors Market in Australia (2021-2030)
• Figure 22: Respiratory Gas Monitors Market in South Korea (2021-2030)
• Figure 23: Respiratory Gas Monitors Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Respiratory Gas Monitors Market in the Rest of the World (2021-2030)
• Figure 25: Respiratory Gas Monitors Market in the Middle East (2021-2030)
• Figure 26: Respiratory Gas Monitors Market in Africa (2021-2030)
• Figure 27: Respiratory Gas Monitors Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER'S Five Force Analysis

Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of respiratory disorders, increasing number of surgical procedures across the globe, and growing demand for anesthesia monitoring.

The rising prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is driving the demand for continuous respiratory monitoring in hospitals and homecare settings. Additionally, the increasing number of surgical procedures worldwide has heightened the need for precise anesthesia monitoring, where respiratory gas monitors play a critical role in tracking oxygen and CO2 levels to ensure patient safety. The growing demand for effective anesthesia care and rising advancements in technology, leading to more product launches and regulatory approvals by key players in the market. These new devices, equipped with enhanced features like wireless connectivity and real-time data analysis, further fuel market growth by meeting the evolving needs of healthcare providers and patients globally. Together, these factors are expected to boost the market of respiratory gas monitors during the forecast period from 2024 to 2030.

Respiratory Gas Monitors Market Dynamics:

According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.

Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffered from chronic respiratory diseases.

Furthermore, according to the recent data and stats provided by World Health Organization (2024), asthma affected an estimated 262 million people globally. The increase in respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), lung infections is significantly driving the market for respiratory gas monitors. With a growing number of patients requiring continuous monitoring of oxygen, carbon dioxide, and other respiratory gases, hospitals and clinics are adopting advanced monitoring systems to provide better care. These devices help detect early signs of respiratory distress, optimize treatment plans, and improve patient outcomes. The rise in chronic respiratory conditions also increases the need for long-term monitoring, both in healthcare facilities and at home, further boosting the demand for portable and non-invasive respiratory gas monitors.

According to the Global Surgery Foundation 2021 reports, about 30% of the global burden of disease is caused by conditions that can be treated by surgery. The increase in surgical procedures globally is driving the demand for respiratory gas monitors, as these devices play a vital role in patient safety during anesthesia administration. Accurate monitoring of gases like oxygen, carbon dioxide, and anesthetic agents is crucial to ensure proper ventilation and prevent complications such as hypoxia or hypercapnia. As the number of surgeries rises-particularly in areas such as cardiovascular, orthopedic, and bariatric procedures-the need for advanced anesthesia monitoring systems grows and thus the demand for respiratory gas monitors esclates. Additionally, complex surgeries often require prolonged anesthesia, making continuous respiratory monitoring essential in both operating rooms and post-anesthesia care units (PACUs). Thus, the adoption of respiratory gas monitors is further bolstered by the rise in number of surgical procedures, where real-time gas monitoring supports quicker patient recovery and discharge.

Thus, the factors mentioned above are likely to boost the market of respiratory gas monitors during the forecasted period.

However, the increased product recalls for respiratory gas monitors and stringent regulatory concerns for product approval may hinder the future market of respiratory gas monitors.

Respiratory Gas Monitors Market Segment Analysis:

Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device segment of the respiratory gas monitors market, pulse oximeters are projected to hold a considerable market share in 2023. Pulse oximeters have significantly influenced the overall market of respiratory gas monitors by providing a cost-effective, non-invasive solution for monitoring patients' oxygen saturation levels (SpO2) and heart rates. Their widespread adoption across various healthcare settings, including hospitals, outpatient clinics, and home care, has driven demand for respiratory monitoring solutions. The ease of use and rapid results offered by pulse oximeters make them an essential tool for healthcare providers, especially in the management of patients with respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and during surgical procedures.

Additionally, the increasing prevalence of respiratory illnesses, coupled with the rising emphasis on remote patient monitoring and telehealth services, has propelled the demand for pulse oximeters, leading to enhanced integration with other respiratory monitoring systems. For instance, as per the recent data provided by the World Health Organization (2023), smoking was a major cause of chronic obstructive pulmonary disease, a common lung condition that led to breathing difficulties and claimed over 3 million lives annually. Approximately 392 million people had COPD, with about 75% living in low- and middle-income countries. In high-income countries, tobacco smoking was responsible for over 70% of COPD cases. Patients with COPD often experience hypoxemia (low blood oxygen levels), necessitating continuous monitoring to ensure appropriate oxygen therapy and prevent exacerbations. Pulse oximeters provide a non-invasive, rapid, and accurate means to assess oxygen saturation levels in patients, enabling healthcare providers to make timely decisions regarding treatment adjustments.

Additionally, the increasing product approval across the globe are further propelling the market of the segment. In February 2024, Masimo announced FDA clearance of MightySat(R) Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.

Therefore, owing to the above-mentioned factors, the pulse oximeter category is expected to generate considerable revenue thereby pushing the overall growth of the global respiratory gas monitors market during the forecast period.

North America is expected to dominate the overall respiratory gas monitors market:

Among all the regions, North America is expected to hold the largest share in the global Respiratory Gas Monitors market in 2023. The rising prevalence of respiratory disorders, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is driving the need for effective monitoring solutions to manage these conditions. Additionally, the growing number of surgical procedures and the heightened focus on patient safety and anesthesia management further contribute to market growth. Furthermore, significant investments in research and development by leading medical device companies in North America are resulting in innovative product launches and technological advancements, enhancing the efficacy and usability of respiratory gas monitors.

According to the recent data and stats provided by American Lung Association (2024), asthma accounted for 10.8% for females and 6.5% for males across the region of United States. Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, characterized by airflow limitation and respiratory symptoms, often leads to hypoxemia, requiring continuous oxygen saturation monitoring to adjust therapies appropriately. Similarly, asthma patients face variable airflow obstruction, which can lead to acute episodes, making real-time monitoring of respiratory gases essential for timely interventions. Therefore, the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma is significantly boosting the market for respiratory gas monitors, as these conditions necessitate effective monitoring and management to ensure optimal patient outcomes.

Furthermore, the increasing number of product development activities in the region is further going to accelerate the growth of the respiratory gas monitors market. For instance, in August 2021, Roundworks Technologies Private Limited announced the approval of 510(k) for its alveoair Digital Spirometer. alveoair(R) is a personal spirometer designed for asthma, COPD, cystic fibrosis and ILD patients to help quantify their lung health.

Therefore, the factors mentioned above are expected to boost the growth of the respiratory gas monitors market in the North America region during the forecast period from 2024 to 2030.

Respiratory Gas Monitors Market Key Players:

Some of the key market players operating in the respiratory gas monitors market include Medtronic plc., Koninklijke Philips N.V., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Stryker, GE Healthcare, ndd Medical Technologies, VYAIRE, Baxter, Contec, Zoll Medical Corporation, ICU Medical, Hamilton Medical, Avante Health Solutions, Nonin, BD, EDAN Instruments, Inc., Criticare Technologies, Inc., and HILLROM, and others.

Recent Developmental Activities in the Respiratory Gas Monitors Market:

• In January, 2024, NuvoAir Medical announced that its innovative Air Next Spirometer had received formal 510(k) clearance for in-home use as a full spirometer.
• In September 2022, RxCap, Inc., a cloud-based remote monitoring company, and ZEPHYRx LLC, a provider of remote respiratory monitoring solutions, announced their partnership to integrate ZEPHYRx's cloud spirometry platform with RxCap's remote monitoring platform.
• In March 2022, KoKo, LLC, a software developer and medical device manufacturer and MAGNET group, a purchasing organizations (GPO) company signed a three-year partnership contract that allows access to all KoKo's "gold standard" lung function diagnostics and software for spirometry, diffusion capacity, and PFT.
• In June 2021, DetelPro launched the Oxy10 pulse oximeter. This compact device has an LED display which can easily be attached to the fingertip, providing readings for oxygen saturation and pulse rate.

Key Takeaways From the Respiratory Gas Monitors Market Report Study:

• Market size analysis for current respiratory gas monitors size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the respiratory gas monitors market.
• Various opportunities available for the other competitors in the respiratory gas monitors market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current respiratory gas monitors market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for respiratory gas monitors market growth in the coming future?

Target Audience who can be Benefited From This Respiratory Gas Monitors Market Report Study:

• Respiratory gas monitors product providers
• Research organizations and consulting companies
• Respiratory gas monitors-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in respiratory gas monitors
• Various end-users who want to know more about the respiratory gas monitors market and the latest technological developments in the respiratory gas monitors market.

Table of Contents

1. Respiratory Gas Monitors Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Respiratory Gas Monitors Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Respiratory Gas Monitors Market Key Factors Analysis

• 5.1. Respiratory Gas Monitors Market Drivers
  • 5.1.1. Rising prevalence of respiratory disorders
  • 5.1.2. Increasing number of surgical procedures across the globe
  • 5.1.3. Increased demand for anesthesia monitoring
• 5.2. Respiratory Gas Monitors Market Restraints and Challenges
  • 5.2.1. Increased product recalls
  • 5.2.2. Stringent regulatory concerns for product approval
• 5.3. Respiratory Gas Monitors Market Opportunities
  • 5.3.1. Integration of artificial intelligence and telehealth services in respiratory gas monitors

6. Respiratory Gas Monitors Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Respiratory Gas Monitors Market Assessment

• 7.1. By Device
  • 7.1.1. Capnographs
  • 7.1.2. Pulse Oximeters
  • 7.1.3. Spirometers
  • 7.1.4. Others
• 7.2. By End User
  • 7.2.1. Hospitals
  • 7.2.2. Clinics
  • 7.2.3. Ambulatory Surgical Centers
  • 7.2.4. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.1.2. Canada Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.1.3. Mexico Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.2.2. Germany Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.2.3. United Kingdom Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.2.4. Italy Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.2.5. Spain Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.2.6. Rest of Europe Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.3.2. Japan Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.3.3. India Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.3.4. Australia Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.3.5. South Korea Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.4.2. Africa Respiratory Gas Monitors Market Size in USD Million (2021-2030)
    • 7.3.4.3. South America Respiratory Gas Monitors Market Size in USD Million (2021-2030)

8. Respiratory Gas Monitors Market Company and Product Profiles

• 8.1. Medtronic plc.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Koninklijke Philips N.V.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Nihon Kohden Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Dragerwerk AG & Co. KGaA
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Stryker
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. GE Healthcare
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. ndd Medical Technologies
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. VYAIRE
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Baxter
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Contec
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Zoll Medical Corporation
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. ICU Medical
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Hamilton Medical
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Avante Health Solutions
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Nonin
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. BD
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. EDAN Instruments, Inc.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Criticare Technologies, Inc.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. HILLROM
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Masimo
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us